BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27789106)

  • 1. Reversible Dilated Cardiomyopathy Caused by a High Burden of Ventricular Arrhythmias in Andersen-Tawil Syndrome.
    Rezazadeh S; Guo J; Duff HJ; Ferrier RA; Gerull B
    Can J Cardiol; 2016 Dec; 32(12):1576.e15-1576.e18. PubMed ID: 27789106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
    Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
    Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
    Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
    Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
    Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
    Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
    Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
    Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.
    Limberg MM; Zumhagen S; Netter MF; Coffey AJ; Grace A; Rogers J; Böckelmann D; Rinné S; Stallmeyer B; Decher N; Schulze-Bahr E
    Basic Res Cardiol; 2013 May; 108(3):353. PubMed ID: 23644778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
    Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
    Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rarity and phenotypic heterogeneity provide challenges in the diagnosis of Andersen-Tawil syndrome: Two cases presenting with ECGs mimicking catecholaminergic polymorphic ventricular tachycardia (CPVT).
    Tully I; Atherton J; Hunt L; Ingles J; Semsarian C; McGaughran J
    Int J Cardiol; 2015 Dec; 201():473-5. PubMed ID: 26322597
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
    Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
    Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome.
    Ördög B; Hategan L; Kovács M; Seprényi G; Kohajda Z; Nagy I; Hegedűs Z; Környei L; Jost N; Katona M; Szekeres M; Forster T; Papp JG; Varró A; Sepp R
    Can J Physiol Pharmacol; 2015 Jul; 93(7):569-75. PubMed ID: 26103554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype variability in patients carrying KCNJ2 mutations.
    Kimura H; Zhou J; Kawamura M; Itoh H; Mizusawa Y; Ding WG; Wu J; Ohno S; Makiyama T; Miyamoto A; Naiki N; Wang Q; Xie Y; Suzuki T; Tateno S; Nakamura Y; Zang WJ; Ito M; Matsuura H; Horie M
    Circ Cardiovasc Genet; 2012 Jun; 5(3):344-53. PubMed ID: 22589293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism.
    Hasegawa K; Ohno S; Kimura H; Itoh H; Makiyama T; Yoshida Y; Horie M
    Clin Genet; 2015 Mar; 87(3):279-83. PubMed ID: 24635491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetic diagnostics of the cause of ventricular arrhythmias in children].
    Brøndberg AK; Bjerre JV; Nielsen JC; Jensen HK
    Ugeskr Laeger; 2015 Sep; 177(38):V04150366. PubMed ID: 26376421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kir 2.1 channelopathies: the Andersen-Tawil syndrome.
    Tristani-Firouzi M; Etheridge SP
    Pflugers Arch; 2010 Jul; 460(2):289-94. PubMed ID: 20306271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
    Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
    Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A→G mutation in KCNJ2.
    Modoni A; Bianchi ML; Vitulano N; Pagliarani S; Perna F; Sanna T; Rizzo V; Silvestri G
    Cardiology; 2011; 120(4):200-3. PubMed ID: 22286118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.
    Vega AL; Tester DJ; Ackerman MJ; Makielski JC
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):540-7. PubMed ID: 19843922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [QTU pattern in a patient with the Anderson-Tawil syndrome].
    Ciurzyński M; Bienias P; Kostera-Pruszczyk A; Pruszczyk P
    Kardiol Pol; 2010 Mar; 68(3):339-41; discussion 342. PubMed ID: 20411461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andersen-Tawil Syndrome: A Comprehensive Review.
    Pérez-Riera AR; Barbosa-Barros R; Samesina N; Pastore CA; Scanavacca M; Daminello-Raimundo R; de Abreu LC; Nikus K; Brugada P
    Cardiol Rev; 2021 Jul-Aug 01; 29(4):165-177. PubMed ID: 32947483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study.
    Sung RJ; Wu SN; Wu JS; Chang HD; Luo CH
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2597-605. PubMed ID: 16877549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.